"PET500 will be marketed as part of Ansell's LifeStyles® brand and it is expected that it will be launched from July in a phased roll-out throughout the USA. We expect recurring royalty income to begin to flow this year but as the launch is phased the initial royalties are likely to be relatively modest."
I joined Futura after more than 35 years at GlaxoSmithKline, most recently as the President of its Consumer Healthcare division. My executive career has given me considerable experience of the consumer healthcare sector, which I believe is reliant on one thing: innovation. Futura is a company with innovation at its core. It also has a great team of people, which it is a privilege for me to join. Its DermaSys® delivery system is at the forefront of transdermal drug delivery, a delivery route that is particularly appealing for OTC products. DermaSys® creates the opportunity for Futura to develop organically into a substantial business. It is my intention to help Futura realise the full potential of its market opportunities whilst also using my experience of global companies to assist in its licensing strategy. 2012 promises to be a very exciting year for Futura with two products close to launch and a pipeline of further opportunities at various stages of development. I look forward to contributing to the Company's success.
Emailed RB to see if they would slip up & give something away. I've fired another off to Ansell. You can only hope.
Our Ref: 001257466A
12 March 2012
Dear Mr ****,
Thank you for your email regarding CSD500 condoms. Please be advised that we are not able to give out information about the CSD500 condoms. The launch date is to be confirmed. As it is a new product and not yet on the market, the information is confidential to the company and is considered to be commercially sensitive. Thank you for your understanding regarding our position on this.
Note the closing date for the competition is 14 April and details were supposed to have been updated yesterday. Keep an eye on this to see if they give any clues that link it to CSD!
"Ok, talented young designers, our friends at Durex have got a challenge for you: they’ve just launched a global contest that will give one up-and-coming designer the chance to have their original artwork printed on the new Durex condom pack and sold around the world. The Durex Naked Box competition is a once in a lifetime opportunity for young designers to work with a global brand and have their art showcased for the world (and your mates) to see. There are hundreds of other prizes up for grabs every week, too, including iPads, underwear, t-shirts and other Durex goodies. To be in with a chance of winning a prize or to vote to help your favourite design to win, log into the Durex Facebook Page. But do it all by the close date on April 17."
off at the end but showing strength. Settlement as of 29/02/2012, at 5:45 p.m. Futura Medical Plc fractionally up, achieving a modest profit of +0.98%. The security opened at the same level as the previous day's close, and then gained steadily throughout trading, but closed down near the session low. Comparing the share price trend with the UK FTSE All Share index on a weekly basis, we see Futura Medical Plc maintaining relative strength over the index, as it exploits a greater performance than the index (weekly share performance of 3.03%, versus a 0.18% gain in the index).
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.